IMRN Rasio cepet Immuron Ltd

This price trend visualization for Immuron Limited (IMRN) demonstrates the asset's dynamics, where the liquidity ratio stands at 5.84. Immuron Limited (IMRN) maintains its position in the specialized immunotherapy segment, competing against the costly advertising campaigns of universal product manufacturers. The business focuses on Australian developments for tourists, expanding its presence through pharmaceutical networks. The brand ecosystem is based on establishing the habit of using immunoglobulins to protect the gut from infections.

Assessing the reliability of equity assets begins with analyzing the issuer's ability to settle short-term debts without liquidating inventory. This quick ratio aggregates cash and accounts receivable, which is critical for Immuron Limited (IMRN) in maintaining a staff of highly qualified biotechnologists and distribution specialists, confirming the company's financial stability during periods of operational spending on human capital.